Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus

NCT00530309 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: GSK716155 for injection
DRUG: Placebo

Sponsor

GlaxoSmithKline